Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Medarex in two deals

Eos (South San Francisco, Calif.) will identify targets for cancer and other diseases, and will use MEDX's HuMAb-Mouse technology to develop human antibodies

Read the full 236 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE